Clinical Trial Update: Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and cardiovascular efficacy of spironolactone in patients with dialysis-dependent end-stage renal disease has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: University of Pennsylvania | Conditions: End-Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-07-23